Muscarinic receptor activation protects against paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells. Sangsuwannukul T, Visitnonthachai D, Watcharasit P, Satayavivad J. Thai J Tox 2015; 236(3): 138-44.

01 Jan 2015
0
0

Muscarinic receptor activation protects against paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Sangsuwannukul T, Visitnonthachai D, Watcharasit P, Satayavivad J.
Thai J Tox 2015; 236(3): 138-44.

Tags

Share this

Related Posts

Tummatorn, J.; Krajangsri, S.; Norseeda, K.; Thongsornkleeb, C.; Ruchirawat, S. A New Synthetic Approach to 6-Unsubstituted Phenanthridine and Phenanthridine-like Compounds under Mild and Metal-free Conditions. Org. Biomol. Chem. 2014, 12, 5077-5081.
28 Dec 2014
0

Tummatorn, J.; Krajangsri, S.; Norseeda, K.; Thongsornkleeb, C.; Ruchirawat, S. A New Synthetic Approach to 6-Unsubstituted Phenanthridine and Phenanthridine-like Compounds under Mild and Metal-free Conditions. Org. Biomol. Chem. 2014, 12, 5077-5081.

Tummatorn, J.; Krajangsri, S.; Norseeda, K.; Thongsornkleeb, C.; Ruchirawat, S. A New Synthetic Approach to 6-Unsubstituted Phenanthridine and Phenanthridine-like Compounds under Mild and Metal-free Conditions. Org. Biomol. Chem. 2014, 12, 5077-5081.
View More
Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells. Kespichayawattana W, Intachote P, Utaisincharoen P, Sirisinha S Microb Pathog36p287-92(2004 May)
28 May 2004
0

Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells. Kespichayawattana W, Intachote P, Utaisincharoen P, Sirisinha S Microb Pathog36p287-92(2004 May)

Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells. Kespichayawattana W, Intachote P, Utaisincharoen P, Sirisinha S Microb Pathog36p287-92(2004 May)
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More